Bernardini I, Rizzo W B, Dalakas M, Bernar J, Gahl W A
J Clin Invest. 1985 Apr;75(4):1124-30. doi: 10.1172/JCI111806.
Plasma and urine free and acyl carnitine were measured in 19 children with nephropathic cystinosis and renal Fanconi syndrome. Each patient exhibited a deficiency of plasma free carnitine (mean 11.7 +/- 4.0 [SD] nmol/ml) compared with normal control values (42.0 +/- 9.0 nmol/ml) (P less than 0.001). Mean plasma acyl carnitine in the cystinotic subjects was normal. Four subjects with Fanconi syndrome but not cystinosis displayed the same abnormal pattern of plasma carnitine levels; controls with acidosis or a lysosomal storage disorder (Fabry disease), but not Fanconi syndrome, had entirely normal plasma carnitine levels. Two postrenal transplant subjects with cystinosis but without Fanconi syndrome also had normal plasma carnitine levels. Absolute amounts of urinary free carnitine were elevated in cystinotic individuals with Fanconi syndrome. In all 21 subjects with several different etiologies for the Fanconi syndrome, the mean fractional excretion of free carnitine (33%) as well as acyl carnitine (26%) greatly exceeded normal values (3 and 5%, respectively). Total free carnitine excretion in Fanconi syndrome patients correlated with total amino acid excretion (r = 0.76). Two cystinotic patients fasted for 24 h and one idiopathic Fanconi syndrome patient fasted for 5 h showed normal increases in plasma beta-hydroxybutyrate and acetoacetate, which suggested that hepatic fatty acid oxidation was intact despite very low plasma free carnitine levels. Muscle biopsies from two cystinotic subjects with Fanconi syndrome and plasma carnitine deficiency had 8.5 and 13.1 nmol free carnitine per milligram of noncollagen protein, respectively (normal controls, 22.3 and 17.1); total carnitines were 11.8 and 13.3 nmol/mg noncollagen protein (controls 33.5, 20.0). One biopsy revealed a mild increase in lipid droplets. The other showed mild myopathic features with variation in muscle fiber size, small vacuoles, and an increase in lipid droplets. In renal Fanconi syndrome, failure to reabsorb free and acyl carnitine results in a secondary plasma and muscle free carnitine deficiency.
对19例患有肾病型胱氨酸病和肾性范科尼综合征的儿童进行了血浆和尿液中游离及酰基肉碱的检测。与正常对照值(42.0±9.0 nmol/ml)相比,每位患者均表现出血浆游离肉碱缺乏(平均11.7±4.0 [标准差] nmol/ml)(P<0.001)。胱氨酸病患者的平均血浆酰基肉碱水平正常。4例患有范科尼综合征但无胱氨酸病的患者表现出相同的血浆肉碱水平异常模式;患有酸中毒或溶酶体贮积症(法布里病)但无范科尼综合征的对照组血浆肉碱水平完全正常。2例肾移植后患有胱氨酸病但无范科尼综合征的患者血浆肉碱水平也正常。患有范科尼综合征的胱氨酸病患者尿中游离肉碱的绝对量升高。在所有21例由多种不同病因导致范科尼综合征的患者中,游离肉碱(33%)和酰基肉碱(26%)的平均排泄分数大大超过正常值(分别为3%和5%)。范科尼综合征患者的游离肉碱总排泄量与总氨基酸排泄量相关(r = 0.76)。2例胱氨酸病患者禁食24小时,1例特发性范科尼综合征患者禁食5小时,血浆β-羟基丁酸酯和乙酰乙酸酯正常增加,这表明尽管血浆游离肉碱水平极低,但肝脏脂肪酸氧化功能完好。对2例患有范科尼综合征且血浆肉碱缺乏的胱氨酸病患者进行肌肉活检,每毫克非胶原蛋白中游离肉碱分别为8.5和13.1 nmol(正常对照为22.3和17.1);总肉碱分别为11.8和13.3 nmol/mg非胶原蛋白(对照为33.5、20.0)。一次活检显示脂滴轻度增加。另一次活检显示轻度肌病特征,肌纤维大小不一、有小空泡且脂滴增加。在肾性范科尼综合征中,无法重吸收游离及酰基肉碱会导致继发性血浆和肌肉游离肉碱缺乏。